Anebulo Pharmaceuticals Announces Preliminary Tender Offer Results

Anebulo Pharmaceuticals has announced preliminary results of its tender offer to purchase 300,000 shares of common stock at $3.50 per share. The offer was oversubscribed, with 4,897,188 shares properly tendered, and the company expects to accept 300,000 shares for an aggregate cost of approximately $1.05 million. Payment for the shares will be made in cash, without interest.